Elsevier

Experimental Cell Research

Volume 318, Issue 17, 15 October 2012, Pages 2200-2214
Experimental Cell Research

Research Article
The neurogenic basic helix-loop-helix transcription factor NeuroD6 enhances mitochondrial biogenesis and bioenergetics to confer tolerance of neuronal PC12-NeuroD6 cells to the mitochondrial stressor rotenone

https://doi.org/10.1016/j.yexcr.2012.07.004Get rights and content

Abstract

The fundamental question of how and which neuronal specific transcription factors tailor mitochondrial biogenesis and bioenergetics to the need of developing neuronal cells has remained largely unexplored. In this study, we report that the neurogenic basic helix-loop-helix transcription factor NeuroD6 possesses mitochondrial biogenic properties by amplifying the mitochondrial DNA content and TFAM expression levels, a key regulator for mitochondrial biogenesis. NeuroD6-mediated increase in mitochondrial biogenesis in the neuronal progenitor-like PC12-NEUROD6 cells is concomitant with enhanced mitochondrial bioenergetic functions, including increased expression levels of specific subunits of respiratory complexes of the electron transport chain, elevated mitochondrial membrane potential and ATP levels produced by oxidative phosphorylation. Thus, NeuroD6 augments the bioenergetic capacity of PC12-NEUROD6 cells to generate an energetic reserve, which confers tolerance to the mitochondrial stressor, rotenone. We found that NeuroD6 induces an adaptive bioenergetic response throughout rotenone treatment involving maintenance of the mitochondrial membrane potential and ATP levels in conjunction with preservation of the actin network. In conclusion, our results support the concept that NeuroD6 plays an integrative role in regulating and coordinating the onset of neuronal differentiation with acquisition of adequate mitochondrial mass and energetic capacity to ensure energy demanding events, such as cytoskeletal remodeling, plasmalemmal expansion, and growth cone formation.

Highlights

► NeuroD6 induces mitochondrial biogenesis in neuroprogenitor-like cells. ► NeuroD6 augments the bioenergetic reserve of the neuronal PC12-NeuroD6 cells. ► NeuroD6 increases the mitochondrial membrane potential and ATP levels. ► NeuroD6 confers tolerance to rotenone via an adaptive mitochondrial response.

Introduction

Mitochondrial dysfunction critically affects the developing and mature central nervous system given its high-energy demand [1], [2]. Autism spectrum disorder (ASD) is the latest identified neurodevelopmental disorder with mitochondrial pertubations [3]. Developing neurons require high levels of ATP to fuel plasmalemmal biogenesis and cytoskeletal assembly associated with axonal and dendritic growth, processes that are estimated to consume approximately 50% of cellular ATP [4]. Since mitochondria produce the large majority of intracellular ATP through the oxidative phosphorylation system (OXPHOS), developing neurons are vitally dependent on robust mitochondrial biogenesis and bioenergetics. OXPHOS involves a series of redox reactions during which electrons are transferred through several multimeric respiratory enzyme complexes I, III, and IV, establishing a mitochondrial membrane potential (ΔΨm) due to proton gradient between the mitochondrial matrix and the inner mitochondrial membrane, with ATP being synthesized by complex V, also called ATP synthase upon return of protons to the mitochondrial matrix [5]. The OXPHOS capacity of mitochondria is under a coordinated bi-genomic regulation due to the limited coding capacity of mitochondrial DNA (mtDNA), which only encodes 13 out of 80 protein subunits composing the OXPHOS system, with the remainder being nuclear-encoded and imported into mitochondria [6]. In contrast, the protein machinery responsible for mitochondrial biogenesis, more precisely mtDNA replication, is solely nuclear-encoded [7]. The mitochondrial-specific transcription factor Tfam is an essential regulator for in vivo mitochondrial biogenesis, as reflected by the early embryonic lethality of Tfam null mice and a limiting determinant of mtDNA copy number [8], [9]. Moreover, decreased Tfam expression levels in neurons of mutant mice result in mitochondrial respiratory chain defects [10], while mtDNA depletion in humans results in severe mitochondrial diseases, such as mtDNA depletion syndrome [11].

Although major progress has been made toward elucidating the transcriptional network regulating mitochondrial biogenesis and bioenergetics via the ubiquitous transcriptional factors NRF-1-NRF-2 and the co-activator PGC-1 [12], little is known about the identity of neuronal-specific transcriptional factors tailoring mitochondrial functions to the onset of neuronal differentiation. Our recent studies have addressed this gap in our knowledge by demonstrating a correlation between mitochondrial mass and expression of the neurogenic basic helix-loop-helix (bHLH) transcription factor NeuroD6 during the early stages of neuronal differentiation [13]. Furthermore, our gene set enrichment analysis of our genome-wide microarray studies has revealed a link between NeuroD6 and a cluster of mitochondrial bioenergetic-related genes [14]. Finally, NeuroD6 sustained the mitochondrial biomass and low levels of ROS during oxidative stress [15]. Thus, the goal of the present study was to determine whether NeuroD6 could coordinate mitochondrial biogenesis and bioenergetics with the onset of neuronal differentiation. This role would be in concordance with NeuroD6 embryonic expression being triggered at E11.5, a time when neuronal progenitor cells undergo cell cycle withdrawal and initiate neuronal differentiation [16], [17]. We found that NeuroD6 mediates mitochondrial biogenesis by concomitantly increasing mtDNA copy number and Tfam expression levels. Furthermore, NeuroD6 promotes mitochondrial bioenergetic functions by increasing the expression of key subunits of the respiratory complexes, the mitochondrial membrane potential and ATP levels, thereby generating an energetic reserve. Finally, NeuroD6 endows the PC12-NEUROD6 cells with tolerance to the mitochondrial stressor rotenone, an inhibitor of the respiratory complex I (NADH: nicotinamide adenine dinucleotide ubiquinone oxidoreductase) by utilizing this increased basal energetic capacity, thus preventing a deleterious mitochondrial bioenergetic deficit and subsequent cell death.

Section snippets

Cell culture

Control PC12 and PC12-NEUROD6 cells (previously called PC12-Nex1) were generated as described [18] and grown in the presence of F12K medium (Invitrogen) containing 15% horse serum (Invitrogen), 2.5% fetal bovine serum (Invitrogen). Since the three generated PC12-NEUROD6 clones (PC12-Nex1-M A, B and C) displayed similar response upon NGF exposure and withdrawal of trophic factors [18], [19], [20], we used the PC12-NEUROD6 clone A to remain consistent with our previous studies pertaining to

NeuroD6 expression Is associated with enhanced mitochondrial biogenesis

On the basis of the correlation between NeuroD6 expression and mitochondrial mass established in our previous studies [13], we investigated whether NeuroD6 could modulate the mitochondrial biomass by enhancing mitochondrial biogenesis. To address this question, we took advantage of our neuronal paradigm, the PC12-NeuroD6 cell line, which constitutively expresses NeuroD6 and spontaneously recapitulates the first three stages of neuronal differentiation with 44% of PC12-NeuroD6 cells being at

Discussion

This study documents for the first time a neurogenic modulation of mitochondrial biogenesis and bioenergetics by the bHLH differentiation factor NeuroD6, which induces neuronal differentiation and cell cycle exit of neuronal progenitor cells during brain development [16], [17]. We report three novel roles for NeuroD6: first, it promotes mitochondrial biogenesis during the early stages of neuronal differentiation. Second, NeuroD6 enhances the bioenergetic capacity of the neuronal-like

Conclusions

In summary, our findings demonstrate two novel roles for NeuroD6 in a neuronal-like context: (1) it stimulates mitochondrial biogenesis by concomitantly increasing mtDNA content and the key mitochondrial-specific regulator TFAM; and (2) it enhances mitochondrial bioenergetic functions by increasing expression levels of specific subunits of the respiratory complexes of the electron transfer chain, resulting in augmented mitochondrial membrane potential and levels of ATP produced by oxidative

Acknowledgments

We thank Dr. Anastas Popratiloff for his expertise in confocal microscopy and quantification analysis and Dr. Thomas Maynard for his expertise in qPCR. The work was supported in part by the National Institutes of Health, National Institute of Neurological Disorders and Stroke (Grant Number R01-NS041391 to A.C.), the Medical Center Facilitating Funds to A.C., by the National Institute of Child Health and Development (P30HD40677), and by the National Center for Research Resources (S10RR025565).

References (70)

  • N. Li et al.

    Mitochondrial complex I inhibitor rotenone induces apoptosis through enhancing mitochondrial reactive oxygen species production

    J. Biol. Chem.

    (2003)
  • Q. Chen et al.

    Production of reactive oxygen species by mitochondria: central role of complex III

    J. Biol. Chem.

    (2003)
  • S.J. Yang et al.

    Activity-dependent transcriptional regulation of nuclear respiratory factor-1 in cultured rat visual cortical neurons

    Neuroscience

    (2006)
  • S.S. Dhar et al.

    Transcriptional coupling of synaptic transmission and energy metabolism: role of nuclear respiratory factor 1 in co-regulating neuronal nitric oxide synthase and cytochrome c oxidase genes in neurons

    Biochem. Biophys. Acta

    (2009)
  • L.L. Lackner et al.

    The molecular mechanism and cellular functions of mitochondrial division

    Biochim. Biophys. Acta

    (2009)
  • V. Voccoli et al.

    Mitochondrial remodeling in differentiating neuroblasts

    Brain Res.

    (2009)
  • R. Betarbet et al.

    Intersecting pathways to neurodegeneration in Parkinson's disease: effects of the pesticide rotenone on DJ-1, alpha synuclein, and the ubiquitin-proteasome system

    Neurobiol. Dis.

    (2006)
  • H. Fukui et al.

    The mitochondrial impairment, oxidative stress and neurodegeneration connection: reality or just an attractive hypothesis?

    Trends Neurosci.

    (2008)
  • Y. Ren et al.

    Selective vulnerability of dopaminergic neurons to microtubule depolymerization

    J. Bio. Chem.

    (2005)
  • Q. Jiang et al.

    Neurotrophic factors stabilize microtubules and protect against rotenone toxicity on dopaminergic neurons

    J. Biol. Chem.

    (2006)
  • S. DiMauro et al.

    Mitochondrial disorders in the nervous system

    Annu. Rev. Neurosci.

    (2008)
  • D.C. Wallace et al.

    Mitochondrial energetics and therapeutics

    Annu. Rev. Pathol. Mech. Dis.

    (2010)
  • D.A. Rossignol et al.

    Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis

    Mol. Psychiatry

    (2012)
  • B.W. Bernstein et al.

    Actin-ATP hydrolysis is a major energy drain for neurons

    J. Neurosci.

    (2003)
  • M.D. Brand et al.

    Assessing mitochondrial dysfunction in cells

    Biochem. J.

    (2011)
  • S. Anderson et al.

    Sequence and organization of the human mitochondrial genome

    Nature

    (1981)
  • D.A. Clayton

    Nuclear–mitochondrial intergenomic communication

    Biofactors

    (1998)
  • N.G. Larsson et al.

    Mitochondrial transcription factor A is necessary for mtDNA maintenance and embryogenesis in mice

    Nat. Genet.

    (1998)
  • M.I. Ekstrand et al.

    Mitochondrial transcription factor A regulates mtDNA copy number in mammals

    Hum. Mol. Genet.

    (2004)
  • L. Sörensen et al.

    Late-onset corticohippocampal neurodepletion attributable to catastrophic failure of oxidative phosphorylation in MILON mice

    J. Neurosci.

    (2001)
  • W.C. Copeland

    Inherited mitochondrial diseases of DNA replication

    Annu. Rev. Med.

    (2008)
  • K.K. Baxter et al.

    The neurogenic basic helix-loop-helix transcription factor NeuroD6 concomitantly increases mitochondrial mass and regulates cytoskeletal organization in the early stages of neuronal differentiation

    ASN Neuro

    (2009)
  • M. Uittenbogaard et al.

    NeuroD6 genomic signature bridging neuronal differentiation to survival via the molecular chaperone network

    J. Neurosci. Res.

    (2010)
  • M. Uittenbogaard et al.

    The neurogenic basic helix-loop-helix transcription factor NeuroD6 confers tolerance to oxidative stress by triggering an antioxidant response and sustaining the mitochondrial biomass

    ASN Neuro

    (2010)
  • M.H. Schwab et al.

    Neuronal basic helix-loop-helix proteins (NEX, NeuroD, NDRF): spatiotemporal expression and targeted disruption of the NEX gene in transgenic mice

    J. Neurosci.

    (1998)
  • Cited by (0)

    View full text